EP2576618
Mótefni gegn mennskum GDF8
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
25.5.2011EP published:
16.8.2017EP application number:
11726005.9
EP translation filed:
4.9.2017Grant published:
15.9.2017EPO information:
European Patent Register
Max expiry date:
24.5.2031Expiry date:
24.5.2026Next due date:
31.5.2026
Title:
ANTIBODIES TO HUMAN GDF8
Timeline
Today
25.5.2011EP application
16.8.2017EP Publication
4.9.2017Translation submitted
15.9.2017Registration published
24.5.2026Expires
Owner
Name:
Regeneron Pharmaceuticals, Inc.Address:
777 Old Saw Mill River Road, 10591, Tarrytown, NY, US
Inventor
Name:
STITT, TrevorAddress:
Ridgewood, NJ, US
Name:
LATRES, EstherAddress:
New York, NY, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
348559 PDate:
26.5.2010Country:
US
Number:
372882 PDate:
12.8.2010Country:
US
Classification
Categories:
C07K 16/22, A61K 39/395, A61P 3/00, A61P 21/00
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 20.4.2018
Expires: 24.5.2019
Payer: PATICE, Ólafur Ragnarsson, hrl.
Number: 9
Paid: 23.4.2019
Expires: 24.5.2020
Payer: PATICE, Ólafur Ragnarsson, hrl.
Number: 10
Paid: 21.4.2020
Expires: 24.5.2021
Payer: Patice ehf.
Number: 11
Paid: 21.4.2021
Expires: 24.5.2022
Payer: Patice ehf.
Number: 12
Paid: 19.4.2022
Expires: 24.5.2023
Payer: Patice ehf.
Number: 13
Paid: 22.4.2023
Expires: 24.5.2024
Payer: Árnason Faktor ehf.
Number: 14
Paid: 19.4.2024
Expires: 24.5.2025
Payer: Árnason Faktor ehf.
Number: 15
Paid: 13.5.2025
Expires: 24.5.2026
Payer: Árnason Faktor ehf.